International Journal of Cancer · 1997 · 97 citations · 20 references
MedicineBiostatisticsOncologyBayesian BiostatisticsCancer ScreeningEpidemiologyCancer Early DetectionCancer SurveillanceColorectal CancerEarly Cancer DetectionPopulation ScreeningScreeningBayesian Log-linear ModelsCancer Screening EpidemiologyCancer Screening StrategiesColorectal Cancer PreventionColorectal Cancer ScreeningGibbs SamplingMaximum Likelihood InferenceMethod Of Maximum Likelihood
Mass screening using the faecal occult blood test (FOBT) can reduce mortality from colorectal cancer. Reliable estimation of FOBT sensitivity is crucial in assessing the potential effectiveness of a mass-screening procedure. Available estimates could be inaccurate because they neglect the temporal aspect of screening. The aim of our study was to estimate the sensitivity of the FOBT in mass screening for colorectal cancer, taking into account the duration of the pre-clinical phase of the disease assessed by the mean sojourn time (MST), and to assess whether MST and FOBT sensitivity differ according to cancer subsite. We analysed data taken from the first round of the mass-screening programme of the department of Calvados (France), involving 164,364 subjects of whom 43.4% participated in FOB screening. MST and sensitivity were estimated using a simple empirical approach, a traditional maximum likelihood method and log-linear modelling using the Bayesian technique of Gibbs sampling. MST was estimated as between 4.5 and 5 years for all subsites combined. According to the Gibbs sampling method, MSTs were 3.5, 6.4 and 2.6 years for proximal colon, distal colon and rectal cancer, respectively. Our estimation methods give a low sensitivity for the FOBT (50%), results for different subsites being closer to each other, slightly higher for proximal cancer. Our results strongly suggest that tumour growth rates are very different according to subsite, slowest for distal cancer and speediest for rectal cancer. Consideration of FOBT sensitivity without MST appears unreliable. Our results by subsite suggest that combining FOBT and sigmoidoscopy could be a good strategy for colorectal cancer screening.
20
Reducing Mortality from Colorectal Cancer by Screening for Fecal Occult Blood
Jack S. Mandel, John H. Bond, Timothy R. Church et al. · New England Journal of Medicine · 1993 · 3.3K citations · Full text
Randomised controlled trial of faecal-occult-blood screening for colorectal cancer
J D Hardcastle, J Chamberlain, Michael HE Robinson et al. · The Lancet · 1996 · 2.8K citations
Randomised study of screening for colorectal cancer with faecal-occult-blood test
O Kronbörg, Claus Fenger, Jørn Olsen et al. · The Lancet · 1996 · 2.5K citations
Medicine, Oncology, Cancer Screening +13
A Comparison of Fecal Occult-Blood Tests for Colorectal-Cancer Screening
James E. Allison, Irene S. Tekawa, Laura J. Ransom et al. · New England Journal of Medicine · 1996 · 626 citations · Full text
Medicine, Oncology, Cancer Screening +16